[Correspondence] International variation in chemotherapy use in cancer – Authors’ reply

May, 05, 2024 | Select Oncology Journal Articles

We thank Wei Han and colleagues for their comments in response to our article.1 Our results show a high degree of heterogeneity, best demonstrated by the reported between-jurisdiction standard deviation (tau) and 95% prediction intervals; our jurisdictional sample sizes will produce high I2 values even if interjurisdictional variation were small.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy